|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:antineoplastic_agent
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
L01BB06
|
|
gptkbp:brand
|
gptkb:Nipent
|
|
gptkbp:CASNumber
|
53910-25-1
|
|
gptkbp:chemicalFormula
|
C11H16N4O4
|
|
gptkbp:contraindication
|
severe renal impairment
|
|
gptkbp:discoveredBy
|
1970s
|
|
gptkbp:eliminationHalfLife
|
5.7 hours
|
|
gptkbp:firstDescribed
|
gptkb:Takashi_Sugimoto
|
|
gptkbp:IUPACName
|
gptkb:(R)-3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
|
|
gptkbp:KEGGID
|
D00454
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
adenosine deaminase inhibitor
|
|
gptkbp:MeSH_ID
|
gptkb:D010410
|
|
gptkbp:metabolism
|
renal
|
|
gptkbp:molecularWeight
|
268.27 g/mol
|
|
gptkbp:origin
|
isolated from Streptomyces antibioticus
|
|
gptkbp:pregnancyCategory
|
D (US)
|
|
gptkbp:PubChem_CID
|
gptkb:DB00639
47653
CHEMBL1387
|
|
gptkbp:routeOfAdministration
|
intravenous
|
|
gptkbp:sideEffect
|
fever
nausea
fatigue
rash
myelosuppression
|
|
gptkbp:UNII
|
1W52F7V2DF
|
|
gptkbp:usedFor
|
gptkb:hairy_cell_leukemia
chronic lymphocytic leukemia
|
|
gptkbp:bfsParent
|
gptkb:multidrug_resistance-associated_protein_1
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
pentostatin
|